Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jennifer Ana Iden
Institution:
Tel Aviv University
Observed institution:
Tel Aviv University
ORCID:
0009-0008-5721-4348
Observed ORCID:
0009-0008-5721-4348
OpenAlex ID:
A5000883140
The Anti-Tumorigenic Role of Cannabinoid Receptor 2 in Colon Cancer: A Study in Mice and Humans
2023
·
Jennifer Ana Iden
, Bitya Raphael-Mizrahi
, et al.
·
International Journal of Molecular Sciences
·
15
PDF
Erythropoietin Receptor (EPOR) Signaling in the Osteoclast Lineage Contributes to EPO-Induced Bone Loss in Mice
2022
·
Zamzam Awida
, Sahar Hiram-Bab
, et al.
·
International Journal of Molecular Sciences
·
11
PDF
The Non-Erythropoietic EPO Analogue Cibinetide Inhibits Osteoclastogenesis In Vitro and Increases Bone Mineral Density in Mice
2021
·
Zamzam Awida
, Almog Bachar
, et al.
·
International Journal of Molecular Sciences
·
7
PDF
The Anti-Tumorigenic Role of Cannabinoid Receptor 2 in Non-Melanoma Skin Cancer
2023
·
Jennifer Ana Iden
, Bitya Raphael-Mizrahi
, et al.
·
International Journal of Molecular Sciences
·
4
PDF
Immunomodulatory function of cannabinoid receptor 2 and its agonist osteogenic growth peptide in health and cancer: a study in mice and humans
2025
·
Jennifer Ana Iden
, Nathalie Ben-Califa
, et al.
·
Oncogene
·
2
PDF
Therapeutic potential of cannabinoid receptor 2 agonist osteogenic growth peptide in lung fibrosis in aged mice
2026
·
Liana Younis
, Valentina Ace
, et al.
·
American Journal of Respiratory Cell and Molecular Biology
PDF
The Non-Erythropoietic EPO Analogue (Cibinetide) Preserves Bone Mass in Mice
2021
·
Zamzam Awida
, Almog Bachar
, et al.
·
Blood
Show more works
View as search
Works count:
7
Citation count:
39
H-index:
4
I10-index:
2
Year
Topic
Type
